A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome*
暂无分享,去创建一个
K. Moriyama | P. Marie | Toshio Matsumoto | M. Yokozeki | H. Nakanishi | K. Hiura | Y. Tanimoto | Kazuya Matsumoto